Here are relevant reports on : continuous-glucose-monitoring-devices-market
-
Asia Pacific In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
The Asia Pacific in vitro diagnostics market is valued at an estimated USD 29.27 billion in 2026 and is projected to reach USD 45.11 billion by 2031 at a CAGR of 9.0% during the forecast period. The Key Players F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), Danaher (US), Sysmex Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., (China)., Siemens Healthineers AG (Germany), bioMérieux (France), Illumina, Inc. (US), Becton, Dickinson and Company (US), and QuidelOrtho Corporation (US).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Latin America In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Disease) - Forecast to 2031
The Latin America in vitro diagnostics (IVD) market, valued at USD 5.48 billion in 2025, stood at USD 5.87 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 8.13 billion by the end of the period. The increasing demand for diagnostic services, along with the growing need for routine and specialized testing, is driving the market. Investments in lab infrastructure, combined with the adoption of automated and standardized diagnostic procedures, contribute to increasing test volumes in both the public and private healthcare sectors.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Middle East & Africa In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Infectious Disease) - Forecast to 2031
The Middle East & Africa in vitro diagnostics (IVD) market, valued at USD 3.33 billion in 2025, stood at USD 3.49 billion in 2026 and is projected to advance at a resilient CAGR of 4.8% from 2026 to 2031, culminating in a forecasted valuation of USD 4.42 billion by the end of the period.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
US Remote Patient Monitoring (RPM) Market by Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End User - Forecast to 2030
The US Remote Patient Monitoring (RPM) Market, valued at US$14.15 billion in 2024, stood at US$16.09 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2025 to 2030, culminating in a forecasted valuation of US$29.13 billion by the end of the period. The US remote patient monitoring industry is driven by technological innovations in FDA-approved wearable devices, mobile health applications, and monitoring solutions.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Europe Remote Patient Monitoring (RPM) Market By Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio), End User - Forecast to 2030
Europe Remote Patient Monitoring (RPM) market, valued at US$6.16 billion in 2024, stood at US$6.87 billion in 2025 and is projected to advance at a resilient CAGR of 10.3% from 2024 to 2030, culminating in a forecasted valuation of US$11.22 billion by the end of the period.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Wearable Healthcare Devices Market by Product (Trackers, Smartwatch, Patches), Type (Diagnostic (Vital Sign, ECG, Glucose), Therapeutic (Pain, Insulin)), Grade (Consumer, Clinical), Channel (Online, Pharmacy), Application (RPM) - Global Forecast to 2030
The global wearable healthcare devices market, valued at US$41.07 billion in 2024, stood at US$45.29 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$75.98 billion by the end of the period. Market growth is driven by rising health awareness, a shift toward preventive care, and the increasing prevalence of chronic conditions in aging populations.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Gastrointestinal Products Market | Gastroenterology Products Market by Devices (Endoscopy, Ablation system, Motility testing, Biopsy devices, Stenting devices, pH monitoring), Diseases (GERD), (IBD), Gastrointestinal cancer), End-User (Hospitals, ASC) - Global Forecast to 2029
The global gastrointestinal products market, valued at US$13.8 million in 2023, stood at US$14.7 million in 2024 and is projected to advance at a resilient CAGR of 6.1% from 2024 to 2029, culminating in a forecasted valuation of US$19.7 million by the end of the period. Market growth can be attributed to the growing prevalence of gastrointestinal diseases such as Crohn's disease, ulcerative colitis, irritable bowel syndrome (IBS), and colorectal cancer, which drives the demand for diagnostic and therapeutic products.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Asia Pacific Blood Glucose Monitoring Devices Market by Product Type (Self-blood glucose monitoring, Professional point of care), Application (Diabetes management, Health & wellness Monitoring), Test Site (Fingertip, Upper arm), End User (Self/Homecare) - Forecast to 2030
The Asia Pacific blood glucose monitoring devices market, valued at USD 3.11 billion in 2024, stood at USD 3.45 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of USD 5.86 billion by the end of the period. The market is set for steady growth, driven by advancements in continuous glucose monitoring (CGM) systems and smart self-monitoring devices that enhance accuracy, enable real-time glucose data access, and improve ease of use. Rising diabetes prevalence, increasing health awareness, and the growing adoption of digital and mobile health solutions are further boosting demand for blood glucose monitoring devices across healthcare settings in the Asia Pacific region.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Cold Chain Monitoring Market Size, Share, Growth & Trends by Sensors and Data Loggers, RFID Devices, Telematics & Telemetry Devices, Networking Devices, Logistics (Storage, Transportation), Application (Pharmaceuticals & Healthcare, Food & Beverages) - Global Forecast to 2030
The global cold chain monitoring market is expected to grow from USD 8.31 billion in 2025 to USD 15.04 billion by 2030, at a compound annual growth rate (CAGR) of 12.6% during the forecast period. The Key Players Carrier (US), Testo SE & Co. KGaA (Germany), Cryoport Inc. (US), ORBCOMM (US), Controlant hf. (Iceland), Zebra Technologies Corp. (US), Xylem (US), Digi International Inc. (US), AgroFresh (US), and Rotronic AG (Switzerland).
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Zero Trust Architecture Market by Solutions (IAM, Microsegmentation, ZTNA, Continuous Monitoring, Least Privilege Access), by Organization Size (SMB, Large Enterprises), by Deployment Mode (On-premise, Cloud), Vertical, and Region - Forecast to 2029
the global zero trust architecture market size is projected to reach USD 38.5 billion by 2028 at a Compound Annual Growth Rate (CAGR) of 17.3% during the forecast period. Palo Alto Networks (US), VMware (US), Zscaler (US), Akamai (US), Microsoft (US), Cisco (US), IBM (US), Citrix (US), Check Point (US), Trellix (US), Forcepoint (US), CrowdStrike (US), Cloudflare (US), Fortinet (US), Google (US), Netskope (US), Perimeter 81 (US), Twingate (US), Appgate (US), Zero Networks (Israel), Versa Networks (US), Axis Security (US), Ivanti (US), NordLayer (US), and GoodAccess (Czech Republic) are the key players and other players in the zero-trust architecture market.
- Published: November 2023
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
